Page last updated: 2024-11-05

ici 204,219 and Carcinoma, Renal Cell

ici 204,219 has been researched along with Carcinoma, Renal Cell in 1 studies

zafirlukast: a leukotriene D4 receptor antagonist

Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.

Research Excerpts

ExcerptRelevanceReference
" Intriguingly, long-term use of zafirlukast decreases cancer risk and leukotriene receptor antagonists inhibit tumor growth, but the mechanisms still remain unexplored."1.72Zafirlukast Induces VHL- and HIF-2α-Dependent Oxidative Cell Death in 786-O Clear Cell Renal Carcinoma Cells. ( Smith, S; van Wijk, SJL; Wolf, C, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Wolf, C1
Smith, S1
van Wijk, SJL1

Other Studies

1 other study available for ici 204,219 and Carcinoma, Renal Cell

ArticleYear
Zafirlukast Induces VHL- and HIF-2α-Dependent Oxidative Cell Death in 786-O Clear Cell Renal Carcinoma Cells.
    International journal of molecular sciences, 2022, Mar-25, Volume: 23, Issue:7

    Topics: Basic Helix-Loop-Helix Transcription Factors; Carcinoma, Renal Cell; Cell Death; Cell Line, Tumor; G

2022